Evidence map›Paper›PMID 25916724›Full record

ArticleHypertension (Dallas, Tex. : 1979)2015

Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo.

David M Hasan, Robert M Starke, He Gu, Katina Wilson, Yi Chu, Nohra Chalouhi, Donald D Heistad, Frank M Faraci, Curt D Sigmund

Abstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Why Are Women Predisposed to Intracranial Aneurysm?Frontiers in cardiovascular medicine · 2022
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

David M HasanFrom the Department of Neurological Surgery (D.M.H., H.G., K.W., Y.C.) and Departments of Pharmacology and Internal Medicine, Carver College of Medicine (Y.C., D.D.H., F.M.F., C.D.S.), University of Department of Internal Medicine, Iowa; Department of Neurological Surgery, University of Virginia, Charlottesville (R.M.S.); Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA (N.C.); and Department of Internal Medicine, Iowa City Veterans Affairs Healthcare System (F.M.F.).
Robert M StarkeFrom the Department of Neurological Surgery (D.M.H., H.G., K.W., Y.C.) and Departments of Pharmacology and Internal Medicine, Carver College of Medicine (Y.C., D.D.H., F.M.F., C.D.S.), University of Department of Internal Medicine, Iowa; Department of Neurological Surgery, University of Virginia, Charlottesville (R.M.S.); Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA (N.C.); and Department of Internal Medicine, Iowa City Veterans Affairs Healthcare System (F.M.F.).
He GuFrom the Department of Neurological Surgery (D.M.H., H.G., K.W., Y.C.) and Departments of Pharmacology and Internal Medicine, Carver College of Medicine (Y.C., D.D.H., F.M.F., C.D.S.), University of Department of Internal Medicine, Iowa; Department of Neurological Surgery, University of Virginia, Charlottesville (R.M.S.); Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA (N.C.); and Department of Internal Medicine, Iowa City Veterans Affairs Healthcare System (F.M.F.).
Katina WilsonFrom the Department of Neurological Surgery (D.M.H., H.G., K.W., Y.C.) and Departments of Pharmacology and Internal Medicine, Carver College of Medicine (Y.C., D.D.H., F.M.F., C.D.S.), University of Department of Internal Medicine, Iowa; Department of Neurological Surgery, University of Virginia, Charlottesville (R.M.S.); Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA (N.C.); and Department of Internal Medicine, Iowa City Veterans Affairs Healthcare System (F.M.F.).
Yi ChuFrom the Department of Neurological Surgery (D.M.H., H.G., K.W., Y.C.) and Departments of Pharmacology and Internal Medicine, Carver College of Medicine (Y.C., D.D.H., F.M.F., C.D.S.), University of Department of Internal Medicine, Iowa; Department of Neurological Surgery, University of Virginia, Charlottesville (R.M.S.); Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA (N.C.); and Department of Internal Medicine, Iowa City Veterans Affairs Healthcare System (F.M.F.).
Nohra ChalouhiFrom the Department of Neurological Surgery (D.M.H., H.G., K.W., Y.C.) and Departments of Pharmacology and Internal Medicine, Carver College of Medicine (Y.C., D.D.H., F.M.F., C.D.S.), University of Department of Internal Medicine, Iowa; Department of Neurological Surgery, University of Virginia, Charlottesville (R.M.S.); Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA (N.C.); and Department of Internal Medicine, Iowa City Veterans Affairs Healthcare System (F.M.F.).
Donald D HeistadFrom the Department of Neurological Surgery (D.M.H., H.G., K.W., Y.C.) and Departments of Pharmacology and Internal Medicine, Carver College of Medicine (Y.C., D.D.H., F.M.F., C.D.S.), University of Department of Internal Medicine, Iowa; Department of Neurological Surgery, University of Virginia, Charlottesville (R.M.S.); Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA (N.C.); and Department of Internal Medicine, Iowa City Veterans Affairs Healthcare System (F.M.F.).
Frank M FaraciFrom the Department of Neurological Surgery (D.M.H., H.G., K.W., Y.C.) and Departments of Pharmacology and Internal Medicine, Carver College of Medicine (Y.C., D.D.H., F.M.F., C.D.S.), University of Department of Internal Medicine, Iowa; Department of Neurological Surgery, University of Virginia, Charlottesville (R.M.S.); Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA (N.C.); and Department of Internal Medicine, Iowa City Veterans Affairs Healthcare System (F.M.F.).
Curt D SigmundFrom the Department of Neurological Surgery (D.M.H., H.G., K.W., Y.C.) and Departments of Pharmacology and Internal Medicine, Carver College of Medicine (Y.C., D.D.H., F.M.F., C.D.S.), University of Department of Internal Medicine, Iowa; Department of Neurological Surgery, University of Virginia, Charlottesville (R.M.S.); Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA (N.C.); and Department of Internal Medicine, Iowa City Veterans Affairs Healthcare System (F.M.F.). curt-sigmund@uiowa.edu.
University of Virginia · USThomas Jefferson University · USNeurological Surgery · US

Funding

Role of the brain Renin-Angiotensin Sys. in Cardiovas and Metabolic RegulationP01HL084207 · NHLBI · UNIVERSITY OF IOWA · PI SIGMUND, CURT DANIEL · 2007 to 2022
$30.2M
Vascular Protection During HypertensionP01HL062984 · NHLBI · UNIVERSITY OF IOWA · PI SIGMUND, CURT DANIEL · 2000 to 2015
$22.2M
Role of Enhancers Regulating Renin Gene ExpressionR37HL048058 · NHLBI · UNIVERSITY OF IOWA · PI SIGMUND, CURT DANIEL · 2006 to 2015
$4.3M
Regulation of Cerebral Blood Flow by Acid-Sensing Ion Channels (ASICs)R01HL113863 · NHLBI · UNIVERSITY OF IOWA · PI FARACI, FRANK M, WEMMIE, JOHN A · 2012 to 2016
$1.9M
TRANSGENIC STUDIES OF THE HUMAN RENIN-ANGIOTENSIN SYSTEMR01HL048058 · NHLBI · UNIVERSITY OF IOWA · PI SIGMUND, CURT DANIEL · 1993 to 2004
$1.8M
Hypertension: Role of Smooth Muscle Cullin-3 and the CRL3 ComplexR01HL125603 · NHLBI · UNIVERSITY OF IOWA · PI SIGMUND, CURT DANIEL · 2015 to 2018
$1.7M
Cerebrovascular Structure in Hypertension: Mechanisms and Contributions to StrokeR01NS072628 · NINDS · UNIVERSITY OF IOWA · PI BAUMBACH, GARY L · 2011 to 2015
$1.6M
Mechanisms of Effect of Aspirin on Cerebral Aneurysms in MiceK08NS082363 · NINDS · UNIVERSITY OF IOWA · PI HASAN, DAVID M. · 2013 to 2017
$846k
Aneurysm Sac Growth as the Etiology of Recurrence in Coiled Cerebral AneurysmsR03NS079227 · NINDS · UNIVERSITY OF IOWA · PI HASAN, DAVID M. · 2012 to 2013
$148k
Role of PPAR-gamma in Cerebral EndotheliumI01BX001399 · VA · IOWA CITY VA MEDICAL CENTER · PI FARACI, FRANK M · 2013 to 2018
–
BLRD VA I01 BX001399NHLBI NIH HHS HL048058NHLBI NIH HHS HL062984NHLBI NIH HHS HL084207NHLBI NIH HHS HL113863NHLBI NIH HHS HL62984NHLBI NIH HHS P01 HL062984NHLBI NIH HHS P01 HL084207NHLBI NIH HHS R01 HL048058NHLBI NIH HHS R01 HL113863NHLBI NIH HHS R01 HL125603NHLBI NIH HHS R37 HL048058NINDS NIH HHS K08 NS082363NINDS NIH HHS K08NS082363NINDS NIH HHS NS72628NINDS NIH HHS R01 NS072628NINDS NIH HHS R03 NS079227NINDS NIH HHS R03NS079227
6 · The paper itself

Abstract

Vascular inflammation plays a critical role in the pathogenesis of cerebral aneurysms. Peroxisome proliferator-activated receptor γ (PPARγ) protects against vascular inflammation and atherosclerosis, whereas dominant-negative mutations in PPARγ promote atherosclerosis and vascular dysfunction. We tested the role of PPARγ in aneurysm formation and rupture. Aneurysms were induced with a combination of systemic infusion of angiotensin-II and local injection of elastase in (1) mice that received the PPARγ antagonist GW9662 or the PPARγ agonist pioglitazone, (2) mice carrying dominant-negative PPARγ mutations in endothelial or smooth muscle cells, and (3) mice that received the Cullin inhibitor MLN4924. Incidence of aneurysm formation, rupture, and mortality was quantified. Cerebral arteries were analyzed for expression of Cullin3, Kelch-like ECH-associated protein 1, nuclear factor (erythroid-derived 2)-like 2, NAD(P)H dehydrogenase (quinone)1 (NQO1), and inflammatory marker mRNAs. Neither pioglitazone nor GW9662 altered the incidence of aneurysm formation. GW9662 significantly increased the incidence of aneurysm rupture, whereas pioglitazone tended to decrease the incidence of rupture. Dominant-negative endothelial-specific PPARγ did not alter the incidence of aneurysm formation or rupture. In contrast, dominant-negative smooth muscle-specific PPARγ resulted in an increase in aneurysm formation (P<0.05) and rupture (P=0.05). Dominant-negative smooth muscle-specific PPARγ, but not dominant-negative endothelial-specific PPARγ, resulted in significant decreases in expression of genes encoding Cullin3, Kelch-like ECH-associated protein 1, and nuclear factor (erythroid-derived 2)-like 2, along with significant increases in tumor necrosis factor-α, monocyte chemoattractant protein-1, chemokine (C-X-C motif) ligand 1, CD68, matrix metalloproteinase-3, -9, and -13. MLN4924 did not alter incidence of aneurysm formation, but increased the incidence of rupture (P<0.05). In summary, endogenous PPARγ, specifically smooth muscle PPARγ, plays an important role in protecting from formation and rupture of experimental cerebral aneurysms in mice.

Indexed as

Aneurysm, RupturedAngiotensin IIAnilidesAnimalsCerebral ArteriesEndothelium, VascularGene Expression RegulationGenes, DominantHypertensionInflammation MediatorsIntracranial AneurysmMiceMice, TransgenicMuscle, Smooth, VascularMutationMyocytes, Smooth Muscle2-chloro-5-nitrobenzanilideAngiotensin IIAnilidesInflammation MediatorsPancreatic ElastasePioglitazonePPAR gammaThiazolidinedionesaneurysminflammationmyocytes, smooth musclepioglitazonesubarachnoid hemorrhage

Identifiers

PMID25916724
PMCPMC4465866
OpenAlexW2145677313

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.